Revance Therapeutics, Inc. (RVNC)

USD 3.07

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 478.45 Million 581.9 Million 531.16 Million 720.22 Million 340.28 Million 226.34 Million
Total Current Assets 338.86 Million 374.72 Million 246.11 Million 450 Million 296.6 Million 207.92 Million
Cash And Short Term Investments 254.46 Million 340.7 Million 225.07 Million 436.5 Million 290.11 Million 175.81 Million
Cash and Cash Equivalents 137.87 Million 108.96 Million 110.62 Million 333.55 Million 171.16 Million 73.25 Million
Short Term Investments 116.58 Million 231.74 Million 114.44 Million 102.94 Million 118.95 Million 102.55 Million
Net Receivables 27.67 Million 11.33 Million 3.34 Million 1.82 Million - 27 Million
Inventory 45.57 Million 18.32 Million 10.15 Million 5.87 Million - 1.00
Other Current Assets 11.14 Million 4.35 Million 7.54 Million 5.79 Million 6.48 Million 5.11 Million
Total Non-Current Assets 139.58 Million 207.17 Million 285.04 Million 270.21 Million 43.68 Million 18.42 Million
Net PPE 90.2 Million 67.75 Million 69 Million 47.13 Million 41.28 Million 14.44 Million
Good Will And Intangible Assets 9.8 Million 104.17 Million 202.29 Million 218.3 Million - -
Good Will - 77.17 Million 146.96 Million 146.96 Million - -
Intangible Assets 9.8 Million 27 Million 55.33 Million 71.34 Million - -
Long-Term Investments 6.87 Million 6.05 Million 5.04 Million 3.44 Million 730 Thousand 730 Thousand
Tax Assets - -6.05 Million -5.04 Million -3.44 Million - -
Other Non Current Assets 32.7 Million 35.23 Million 13.74 Million 4.77 Million 1.66 Million 3.24 Million
Other Assets - - - - - -
Total Liabilities 630.05 Million 569.3 Million 462.69 Million 345.93 Million 114.79 Million 80.72 Million
Total Current Liabilities 89.22 Million 75.68 Million 67.28 Million 60.96 Million 40.97 Million 31.97 Million
Account Payables 13.8 Million 4.54 Million 10.6 Million 12.65 Million 8.01 Million 8.43 Million
Tax Payables - - - - - -
Short Term Debt 10.85 Million 4.91 Million 4.74 Million 4.43 Million 3.47 Million 14.4 Million
Deferred Revenue 10.73 Million 6.86 Million 9.36 Million 7.85 Million 7.91 Million 8.58 Million
Other Current Liabilities 53.82 Million 59.35 Million 42.57 Million 36.01 Million 21.58 Million 541 Thousand
Total Non Current Liabilities 540.83 Million 493.61 Million 395.4 Million 284.96 Million 73.81 Million 48.75 Million
Long-Term Debt 426.59 Million 413.55 Million 319.76 Million 207.67 Million 25.87 Million -
Deferred Revenue Non Current 70.41 Million 78.57 Million 74.15 Million 77.29 Million 47.94 Million 42.68 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.83 Million 1.48 Million 1.48 Million -180.52 Million 47.94 Million 6.07 Million
Other Liabilities - - - - - -
Total Equity -151.6 Million 12.6 Million 68.47 Million 374.29 Million 225.49 Million 145.62 Million
Stock Holders Equity -151.6 Million 12.6 Million 68.47 Million 374.29 Million 225.49 Million 145.62 Million
Common Stock 88 Thousand 82 Thousand 72 Thousand 69 Thousand 52 Thousand 37 Thousand
Retained Earnings -2.07 Billion -1.75 Billion -1.39 Billion -1.12 Billion -844.2 Million -684.77 Million
Accumulated other comprehensive income 14 Thousand -374 Thousand -18 Thousand - 3000.00 -8000.00
Common Stock Equity -151.6 Million 12.6 Million 68.47 Million 374.29 Million 225.49 Million 145.62 Million
Capital Lease Obligation 40.98 Million 39.09 Million 43.87 Million 31.58 Million 29.34 Million -
Total Investments 123.45 Million 231.74 Million 114.44 Million 102.94 Million 118.95 Million 102.55 Million
Total Debt 478.43 Million 418.46 Million 324.51 Million 212.1 Million 29.34 Million -
Net Debt 340.55 Million 309.5 Million 213.88 Million -121.44 Million -141.82 Million -73.25 Million

Balance Sheet Charts